Isoflavones and Magnolia Extract in the Quality of Life in Menopausal Women
Completed
- Conditions
- Menopause
- Interventions
- Dietary Supplement: isoflavones combined with magnolia
- First Posted Date
- 2013-03-06
- Last Posted Date
- 2014-11-05
- Lead Sponsor
- Rottapharm Spain
- Target Recruit Count
- 100
- Registration Number
- NCT01805674
- Locations
- 🇪🇸
Surgery of Dr. Sánchez Muñoz, Ciudad Real, Spain
🇪🇸ClÃnica ginecológica Cecchini, Oviedo, Spain
🇪🇸Centro Médico Teknon, Barcelona, Spain
Combined Effects of Bioactive Compounds in Lipid Profile
Phase 2
Completed
- Conditions
- HyperlipidemiaLow-density-lipoprotein-typeElevated Triglycerides
- Interventions
- Dietary Supplement: Armolipid PlusDietary Supplement: placebo
- First Posted Date
- 2012-03-23
- Last Posted Date
- 2013-02-28
- Lead Sponsor
- Rottapharm Spain
- Target Recruit Count
- 118
- Registration Number
- NCT01562080
- Locations
- 🇪🇸
Hosp. Universitario San Joan, Reus, Tarragona, Spain
Trial to Evaluate the Effect of Plantago Ovata Husk in the Remission of Metabolic Syndrome in Children and Adolescents
- First Posted Date
- 2008-09-09
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Rottapharm Spain
- Target Recruit Count
- 19
- Registration Number
- NCT00748787
- Locations
- 🇪🇸
Hospital Universitari San Joan de Reus, Reus, Tarragona, Spain
Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight
Phase 2
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: placeboDrug: Megestrol acetate
- First Posted Date
- 2007-07-27
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Rottapharm Spain
- Target Recruit Count
- 40
- Registration Number
- NCT00507949
- Locations
- 🇪🇸
Neumology Service of the Hospital Universitario Dr. Peset, Valencia, Spain
Study of the Modification of the Pharmacokinetic Profile of Levodopa by the Fiber Plantago Ovata Husk
Phase 1
Completed
- Conditions
- Parkinson's Disease, Idiopathic
- Interventions
- Drug: Plantago ovata huskOther: hemicellulose crystalline
- First Posted Date
- 2007-07-26
- Last Posted Date
- 2007-07-26
- Lead Sponsor
- Rottapharm Spain
- Target Recruit Count
- 18
- Registration Number
- NCT00507715
- Locations
- 🇪🇸
Hospital de León, Leon, León, Spain
Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients
- First Posted Date
- 2007-07-18
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Rottapharm Spain
- Target Recruit Count
- 39
- Registration Number
- NCT00503516
- Locations
- 🇪🇸
Hospital Socio Sanitario del Hospitalet, El Hospitalet, Barcelona, Spain
Effect of the Plantago Ovata Husk on the Lipid Profile of Patients With Hypercholesterolemia
Phase 2
Completed
- Conditions
- Cardiovascular DiseaseHypercholesterolemia
- First Posted Date
- 2007-07-17
- Last Posted Date
- 2007-07-17
- Lead Sponsor
- Rottapharm Spain
- Target Recruit Count
- 255
- Registration Number
- NCT00502047
- Locations
- 🇪🇸
Hosp. Universitario San Joan de Reus, (Spain), Reus, Tarragona, Spain
Pharmacodynamic Trial, of Slow Release ASA, in Platelet Functionalism, a Long Term Treatment Period
Phase 2
Completed
- Conditions
- Cardiovascular Disease
- First Posted Date
- 2007-07-16
- Last Posted Date
- 2007-07-18
- Lead Sponsor
- Rottapharm Spain
- Target Recruit Count
- 100
- Registration Number
- NCT00501254
- Locations
- 🇪🇸
Hospital Universitario Virgen de la Victoria, Málaga, Spain
Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.
Phase 1
Completed
- Conditions
- Cardiovascular Disease
- Interventions
- First Posted Date
- 2007-01-22
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Rottapharm Spain
- Target Recruit Count
- 50
- Registration Number
- NCT00425074
- Locations
- 🇪🇸
Hospital Universitario Virgen de la Victoria, Málaga, Spain
© Copyright 2025. All Rights Reserved by MedPath